PMC:7600245 / 63915-64086
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T646 | 18-19 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T647 | 75-78 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T45211 | 31-46 | Chemical | denotes | imidazothiazole | http://purl.obolibrary.org/obo/CHEBI_48909 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T492 | 1-11 | Sentence | denotes | Levamisole |
| T493 | 12-125 | Sentence | denotes | It is a tetrahydro-imidazothiazole derivative (Figure S6) that has been used for its immunomodulatory properties. |
| T494 | 126-169 | Sentence | denotes | It was first introduced by Janssen in 1969. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2003 | 1-11 | Chemical | denotes | Levamisole | MESH:D007978 |
| 2014 | 20-46 | Chemical | denotes | tetrahydro-imidazothiazole |